Astera Labs Inc’s recently made public that its General Counsel and Secretary Mazzara Philip unloaded Company’s shares for reported $1.89 million on Aug 28 ’25. In the deal valued at $188.70 per share,10,000 shares were sold. As a result of this transaction, Mazzara Philip now holds 161,573 shares worth roughly $28.15 million.
Then, CASA ALAMEDA 2007, LLC bought 33,000 shares, generating $6,012,600 in total proceeds.
Before that, ALBA 2003 LIVING TRUST bought 150,000 shares. Astera Labs Inc shares valued at $27,330,000 were divested by the Director at a price of $182.20 per share.
Northland Capital downgraded its Astera Labs Inc [ALAB] rating to a Market perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late May with a ‘”an Outperform”‘ rating. Susquehanna began covering ALAB with “Neutral” recommendation on May 16, 2025. Morgan Stanley revised its rating on May 12, 2025. It rated ALAB as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of ALAB
On Tuesday, Astera Labs Inc [NASDAQ:ALAB] saw its stock fall -4.37% to $174.24. Over the last five days, the stock has gained 0.05%. Astera Labs Inc shares have risen nearly 300.37% since the year began. Nevertheless, the stocks have risen 31.55% over the past one year. While a 52-week high of $199.47 was reached on 08/13/25, a 52-week low of $36.85 was recorded on 04/04/25.
Levels Of Support And Resistance For ALAB Stock
The 24-hour chart illustrates a support level at 167.59, which if violated will result in even more drops to 160.95. On the upside, there is a resistance level at 180.79. A further resistance level may holdings at 187.35.
How much short interest is there in Astera Labs Inc?
A steep rise in short interest was recorded in Astera Labs Inc stocks on 2025-08-15, dropping by -2.17 million shares to a total of 9.0 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 11.17 million shares. There was a decline of -24.09%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 14, 2025 when Raymond James began covering the stock and recommended ‘”an Outperform”‘ rating along with a $82 price target.
